Articles related to PRECISION MEDICINE

Explore the transformative potential of antibody-drug conjugates (ADCs) in cancer therapy, offering targeted treatments with reduced side effects. Recent approvals and ongoing trials signify a significant shift towards precision medicine in oncology.

This study illuminates the potential of preoperative circulating tumor DNA to redefine the approach to treating high-risk upper tract urothelial carcinoma, offering a nuanced tool for assessing the necessity of neoadjuvant chemotherapy and tailoring patient care.

In an exciting development for schizophrenia research, Dr. Pan Li’s team utilizes CRISPR/Cas9 to explore neuron cell development, focusing on rare gene variants.

In the rapidly evolving field of oncology, artificial intelligence (AI) stands out not just for its potential to revolutionize cancer care, but also for the complex ethical and practical challenges it presents. A recent survey highlights both the enthusiasm and caution among oncologists regarding AI’s integration into clinical practice.

UT Southwestern’s pioneering use of SCINTIX biology-guided radiotherapy represents a major advancement in precision oncology, targeting bone and lung cancers with a novel approach that combines PET imaging and radiotherapy for more effective treatment.

AI’s transformative role in breast cancer care goes beyond prediction—it offers a nuanced evaluation of both cancerous and non-cancerous elements, guiding individualized treatment plans. Learn how this innovation minimizes unnecessary chemotherapy, prioritizes patient outcomes, and heralds a new era in precision medicine.